Why Is The Mesoblast (MESO) Stock Rising In Pre-Hours Trading?

MRAI Stock

The shares of global leader in allogeneic cellular medicines for inflammatory diseases,  Mesoblast Limited (NASDAQ: MESO) are rising on the charts today, up 10.80% to $8.00 at last check-in premarket trades. Mesoblast stock closed Thursday session at $7.22, falling -1.37%. The volume for MESO stock was 0.48 million, compared to 281.32K daily average. For positive […]

Is that why Mesoblast Limited (MESO) dipped in the early morning trading?

ASTR Stock

Mesoblast Limited (Nasdaq:MESO) shares were plunging -30.07 to $9.45 in the premarket session recently released an update on the clinical trial of remestemcel-L in ventilator-dependent patients with moderate to severe acute respiratory distress syndrome (ARDS) caused by infection with COVID-19 following a third interim analysis of the first 180 patients in the trial by the […]